References
- Kjeld J. M., Kuku S. F., Diamant L., Fraser T. R., Joblin G. F., Mashiter K. Production and storage of [125I] thyroxine and [125I] triiodothyronine of high specific activity. Clin chim. Acta 1975; 61: 381
- Kochupillai N., Yalow R. S. Preparation, purification, and stability of high specific activity 125I-labelled thyronines. Endocrinology 1978; 102: 128
- Ködding R., von zur Mühlen A. Untersuchungen zur Herstellung von 125J-markiertem Trijodthyronin und Thyroxin mit hoher spezifischer Radioaktivität. Z. Klin. Chem. Klin. Biochem 1975; 13: 563
- Laurberg P. Non-parallel variations in the preferential secretion of 3,5,3′-triiodothyronine (T3) and 3,3′,5′-triiodothyronine (rT3) from dog thyroid. Endocrinology 1978; 102: 757
- Reese M. G., Hales R. H. The production and characterization of medium and high suecific activity 125I-T3 and 125I-T4 utilizing substitution and exchange mechanisms. J. Lab. Compnds. Radio-pharmaceut 1978; 15: 555
- Rokos H. Bromoiodothyronines—intermediates for radiochemically stable high specific activity 125I tracers and tools for studying deiodination. Thyroid Research VIII, J. R. Stockigt, S. Nagataki. The Australian Academy of Science, Canberra 1980; 349
- Thurlow V. R., Puxley H. J. Preparation of 125I-thyroxine and 125I-triiodothyronine of high specific activity for the radioimmunoassay of serum total T4 and T3. Ann. clin. Biochem 1976; 13: 364
- Weeke J., Ørskov H. Synthesis of 125I mono-labelled 3,5,3′-triiodothyronine and thyroxine of maximum specific activity for radioimmunoassay. Scand. J. clin. Lab. Invest 1973; 32: 357